← Back to Clinical Trials
Recruiting NCT06700018

NCT06700018 Flow Patterns and Stent Thrombosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06700018
Status Recruiting
Phase
Sponsor Queen Mary University of London
Condition Stent Thrombosis
Study Type OBSERVATIONAL
Enrollment 120 participants
Start Date 2024-04-01
Primary Completion 2026-07-14

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 120 participants in total. It began in 2024-04-01 with a primary completion date of 2026-07-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to study the effect of haemodynamic forces on thrombus formation and identify haemodynamic markers that predict stent thrombosis events in patients who have undergone OCT-guided percutaneous coronary interventions. The primary objective of the study is to examine the efficacy of blood flow patterns in predicting stent thrombosis. Researchers will compare the blood flow patterns of the stent thrombosis group with that of the control group to understand the influence of blood flow patterns on thrombus formation and progression.

Eligibility Criteria

Inclusion Criteria: * Patients undergone OCT-guided percutaneous coronary intervention and implanted with a second-generation drug-eluting stent * Patients who have suffered thrombosis post-stent implantation Exclusion Criteria: \-

Contact & Investigator

Central Contact

Christos Bourantas

✉ c.bourantas@qmul.ac.uk

📞 +442073777000

Frequently Asked Questions

Who can join the NCT06700018 clinical trial?

This trial is open to participants of all sexes, studying Stent Thrombosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06700018 currently recruiting?

Yes, NCT06700018 is actively recruiting participants. Contact the research team at c.bourantas@qmul.ac.uk for enrollment information.

Where is the NCT06700018 trial being conducted?

This trial is being conducted at London, United Kingdom.

Who is sponsoring the NCT06700018 clinical trial?

NCT06700018 is sponsored by Queen Mary University of London. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology